- Home
- TCRT vs GCTK Comparison
TCRT vs GCTK Comparison
Compare TCRT & GCTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCRT
- GCTK
- Stock Information
- Founded
- TCRT 1998
- GCTK 2001
- Country
- TCRT United States
- GCTK United States
- Employees
- TCRT N/A
- GCTK N/A
- Industry
- TCRT Biotechnology: Pharmaceutical Preparations
- GCTK Medical/Dental Instruments
- Sector
- TCRT Health Care
- GCTK Health Care
- Exchange
- TCRT Nasdaq
- GCTK Nasdaq
- Market Cap
- TCRT 3.8M
- GCTK 3.7M
- IPO Year
- TCRT N/A
- GCTK N/A
- Fundamental
- Price
- TCRT $2.74
- GCTK $6.23
- Analyst Decision
- TCRT
- GCTK
- Analyst Count
- TCRT 0
- GCTK 0
- Target Price
- TCRT N/A
- GCTK N/A
- AVG Volume (30 Days)
- TCRT 58.1K
- GCTK 1.2M
- Earning Date
- TCRT 08-13-2025
- GCTK 08-12-2025
- Dividend Yield
- TCRT N/A
- GCTK N/A
- EPS Growth
- TCRT N/A
- GCTK N/A
- EPS
- TCRT N/A
- GCTK N/A
- Revenue
- TCRT $11,000.00
- GCTK N/A
- Revenue This Year
- TCRT $5,680,500.00
- GCTK N/A
- Revenue Next Year
- TCRT N/A
- GCTK N/A
- P/E Ratio
- TCRT N/A
- GCTK N/A
- Revenue Growth
- TCRT 83.33
- GCTK N/A
- 52 Week Low
- TCRT $1.31
- GCTK $5.11
- 52 Week High
- TCRT $6.20
- GCTK $3,756.00
- Technical
- Relative Strength Index (RSI)
- TCRT 34.42
- GCTK 45.91
- Support Level
- TCRT $2.69
- GCTK $6.90
- Resistance Level
- TCRT $3.15
- GCTK $8.85
- Average True Range (ATR)
- TCRT 0.38
- GCTK 0.80
- MACD
- TCRT -0.10
- GCTK 0.01
- Stochastic Oscillator
- TCRT 16.00
- GCTK 24.14
About TCRT Alaunos Therapeutics Inc.
Alaunos Therapeutics Inc is a clinical-stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy. It strikes cancer at its core by engineering cell therapies that target Neoantigens arising from genomic mutations. It has a single reportable and operating segment related to biopharmaceutical research and development.
About GCTK GlucoTrack Inc.
GlucoTrack Inc is a medical device company. It is focused on defining novel approaches that make diabetes management more accurate and convenient for daily living. The company has developed the GlucoTrack model that measures real-time blood glucose levels. The Company is developing an long-term implantable continuous blood glucose monitoring (CBGM) system, built on proven healthcare technologies. It is designed to meet the critical needs of insulin-dependent individuals or those at risk of hypoglycemia in the U.S.